Educational, not medical advice. Talk with a licensed Georgia provider about your care.
Get your card

Law updates

What’s changed recently

A lot has shifted — much of it progress. We track the changes that matter to Georgia patients and frame each one precisely, with sources.

Verified as of 2026-06-28. We link primary sources; verify before relying on any detail.

  1. Jul 1, 2026

    Georgia's expanded medical cannabis program takes effect (SB 220)

    The "Putting Georgia's Patients First Act" is now in effect — a major expansion. It renames the program "medical cannabis" and legalizes vaporization; smoking and edibles stay prohibited.

    • Removes the old 5% THC cap; new limits are 12,000 mg total THC per patient and 1,200 mg per package.
    • Legalizes vaporization for patients 21+, including dry-herb flower for a vaporizer. Smoking and edibles remain prohibited.
    • Vaporizer products and flower are available at major dispensaries (Trulieve, Fine Fettle, Botanical Sciences) as of July 1, 2026.
    • Renames “low THC oil” to “medical cannabis” and the registry to the Medical Cannabis Patient Registry; adds conditions (lupus, inflammatory bowel disease).

    Sources: Marijuana Moment · NORML

  2. Jun 29, 2026

    DEA Hearings on Cannabis Rescheduling Begin

    The DEA is officially holding a historic hearing to consider transferring all remaining marijuana (including adult-use) from Schedule I to Schedule III.

    • The proceedings will continue into mid-July

    Sources: MPP

  3. Jun 18, 2026

    Supreme Court sides with a cannabis-using gun owner — narrowly

    In United States v. Hemani, the Court ruled this prosecution unconstitutional. It's real progress against stigma — but a narrow, as-applied decision, not a blanket restoration of gun rights.

    • The Court held that prosecuting this marijuana user under 18 U.S.C. § 922(g)(3) violated the Second Amendment.
    • It is as-applied and narrow: § 922(g)(3) still stands, and cases involving other drugs, addiction, or intoxication were expressly left open.
    • Separately, the ATF posted a draft revision of Form 4473 narrowing the marijuana question toward recreational use — still in the public-comment stage, not final.

    Sources: SCOTUSblog — case · SCOTUSblog — analysis

  4. Apr 23, 2026

    Federal government moves some cannabis to Schedule III

    A narrow final order — not a blanket rescheduling. It covers FDA-approved and state-licensed medical cannabis only.

    • FDA-approved marijuana products and state-licensed medical marijuana move from Schedule I to Schedule III.
    • Recreational, unlicensed, and synthetically-derived marijuana remain Schedule I.
    • A broader rescheduling hearing continued into mid-2026. This did not federally legalize recreational use.

    Sources: Federal Register

  5. Apr 1, 2026

    Medicare launches a hemp-product pilot

    A real federal pilot — but narrower than the headlines. It runs through traditional-Medicare ACO models, not Medicare Advantage, and "3 mg" is a ceiling, not a dose offered.

    • The CMS Substance Access Beneficiary Engagement Incentive (BEI) lets participating organizations furnish up to $500/year of hemp-derived products per beneficiary.
    • Eligible products are federally legal hemp (≤0.3% delta-9 THC) and exclude any oral product over 3 mg total THC per serving, plus inhalables and synthetics.
    • It operates through ACO REACH and the Enhancing Oncology Model — not Medicare Advantage — and Medicare does not reimburse the products.

    Sources: CMS · Foley & Lardner analysis

  6. Feb 9, 2026

    As legalization spreads, teen cannabis use keeps falling

    National surveys put adolescent cannabis use at multi-decade lows — the opposite of the teen-use surge many feared as states legalized.

    • Monitoring the Future — the federal government’s gold-standard annual survey (University of Michigan, funded by NIDA) — reported teen cannabis use near a 30-year low in 2024. Past-year use among 12th graders fell to 25.8% (from 29.0% in 2023); use in younger grades held steady.
    • The CDC’s Youth Risk Behavior Survey trend report found current (past-30-day) marijuana use among high schoolers fell about 26% from 2013 to 2023 — part of a broad, decade-long decline in adolescent substance use.
    • A peer-reviewed analysis of YRBS data (Addictive Behaviors, Feb 2026) confirmed the long slide: current use dropped from 27.1% in 1999 to 17.8% in 2023.
    • One honest caveat: these are national time trends. They show youth use fell during the legalization era — not that legalization caused the drop. But they directly contradict predictions that legal access would send teen use soaring.

    Sources: Monitoring the Future (NIDA, Dec 2024) · CDC Youth Risk Behavior Survey, 2013–2023 · Addictive Behaviors (peer-reviewed YRBS analysis, Feb 2026)

  7. Nov 12, 2025

    Federal hemp redefinition signed — effective ~Nov 2026

    A law that could "end hemp as we know it." It redefines hemp by total THC and takes effect about a year after enactment.

    • P.L. 119-37 redefines hemp to ≤0.3% total THC (including THCA and delta-8) plus a 0.4 mg total-THC per-container ceiling, and excludes synthesized cannabinoids.
    • It takes effect ~November 12, 2026 (365 days after enactment); industry estimates it would eliminate ~95% of current hemp-cannabinoid products.
    • Delay bills (S.3686 / H.R.7010, pushing the date to 2028) had not advanced as of mid-2026. See our hemp page for Georgia impact.

    Sources: Congress.gov CRS

  8. Apr 15, 2024

    The studies — legalizing cannabis hasn't raised teen use

    Research comparing states that legalized to those that didn't finds no increase in adolescent use — and one large study found a modest decrease.

    • A JAMA Pediatrics study (April 2024) of roughly 898,000 students across 47 states (2011–2021) found recreational legalization “was not associated” with adolescents’ likelihood or frequency of cannabis use — no net increase — and was tied to modest decreases in teen alcohol and e-cigarette use.
    • An earlier JAMA Pediatrics study (2019) of 1.4 million adolescents found recreational-legalization states saw roughly an 8% decrease in the odds of teen use. The researchers suggest licensed, age-checked stores displace illicit dealers who don’t card.
    • In King County, Washington (the Seattle area), the CDC’s MMWR reported high-school cannabis use fell after the state’s 2014 adult-use retail launch.
    • The takeaway, stated carefully: the best available research finds adult-use legalization has not been associated with increased teen use — and several national and state surveys show youth use has actually declined over the same period.

    Sources: JAMA Pediatrics (Boston College, Apr 2024) · JAMA Pediatrics (Anderson et al., 2019) · CDC MMWR — King County, WA (Jan 2024)